{"id":2959,"date":"2025-04-17T12:59:36","date_gmt":"2025-04-17T12:59:36","guid":{"rendered":"https:\/\/haber360.com\/index.php\/2025\/04\/17\/hematoloji-incelemelerinde-tibbi-yazim-trendleri\/"},"modified":"2025-04-17T12:59:36","modified_gmt":"2025-04-17T12:59:36","slug":"hematoloji-incelemelerinde-tibbi-yazim-trendleri","status":"publish","type":"post","link":"https:\/\/haber360.com\/index.php\/2025\/04\/17\/hematoloji-incelemelerinde-tibbi-yazim-trendleri\/","title":{"rendered":"Hematoloji \u0130ncelemelerinde T\u0131bbi Yaz\u0131m Trendleri"},"content":{"rendered":"<p>Son y\u0131llarda t\u0131bbi yaz\u0131m hizmetleri, \u00f6zellikle hematoloji alan\u0131nda haz\u0131rlanan bilimsel makalelerde hem etkili hem de tart\u0131\u015fmal\u0131 bir rol \u00fcstlenmektedir. Ba\u015flang\u0131\u00e7ta karma\u015f\u0131k ara\u015ft\u0131rma makalelerinin haz\u0131rlanmas\u0131n\u0131 kolayla\u015ft\u0131rmay\u0131 hedefleyen bu hizmetler, zamanla etik kayg\u0131lar\u0131 da beraberinde getirmi\u015ftir. End\u00fcstri etkisinin akademik yay\u0131na s\u0131zma riski, t\u0131bbi yaz\u0131m\u0131n kullan\u0131m\u0131nda \u015feffafl\u0131k ve \u00e7\u0131kar \u00e7at\u0131\u015fmalar\u0131 konusundaki endi\u015feleri art\u0131rmaktad\u0131r. BMC Cancer dergisinde yay\u0131mlanan son bir analiz, hematolojik maligniteler \u00fczerine odaklanan derleme makalelerde t\u0131bbi yaz\u0131m\u0131n yayg\u0131nl\u0131\u011f\u0131 ve finansman kaynaklar\u0131n\u0131 ortaya koyarak bu alandaki kritik durumu g\u00f6zler \u00f6n\u00fcne sermi\u015ftir.<\/p>\n<p>Onkoloji ve malign hematoloji klinik denemelerinde t\u0131bbi yaz\u0131m hizmetlerinin yayg\u0131n kullan\u0131m\u0131 iyi bilinmekle birlikte, derleme makalelerinde bu hizmetlerin kapsam\u0131 ve etkisi yeterince ara\u015ft\u0131r\u0131lmam\u0131\u015ft\u0131r. S\u00f6z konusu yeni \u00e7al\u0131\u015fma, bu bo\u015flu\u011fu doldurmak amac\u0131yla 2019-2023 y\u0131llar\u0131 aras\u0131nda hematoloji alan\u0131nda en y\u00fcksek etki fakt\u00f6r\u00fcne sahip ilk 10 dergide yay\u0131mlanan farkl\u0131 t\u00fcrde derleme makaleleri sistematik olarak incelemi\u015ftir. \u0130nceleme kapsam\u0131nda anlat\u0131sal ve sistematik derlemelerin yan\u0131 s\u0131ra klinik rehberler ve tedavi \u00f6nerileri sunan makaleler de yer al\u0131rken, temel bilimler ve iyi huylu hematoloji \u00e7al\u0131\u015fmalar\u0131 kapsam d\u0131\u015f\u0131 b\u0131rak\u0131lm\u0131\u015ft\u0131r.<\/p>\n<p>Toplam 663 derleme makalesinin analiz edildi\u011fi \u00e7al\u0131\u015fmada, sadece %5,7 oran\u0131nda t\u0131bbi yaz\u0131m yard\u0131m\u0131 kullan\u0131ld\u0131\u011f\u0131 a\u00e7\u0131k\u00e7a beyan edilmi\u015ftir. \u0130lgin\u00e7tir ki, bu makalelerde t\u0131bbi yazarlar yazar kadrosunda yer almam\u0131\u015f ve hak ettikleri katk\u0131 pay\u0131n\u0131 alamam\u0131\u015flard\u0131r. Baz\u0131 dergilerde bu oran anlaml\u0131 \u00f6l\u00e7\u00fcde daha y\u00fcksek bulunmu\u015f; bir derginin %21 oran\u0131 ile \u00f6ne \u00e7\u0131kmas\u0131, t\u0131bbi yaz\u0131m\u0131n tan\u0131nmas\u0131 ve bildirilmesinde dergiler aras\u0131ndaki farkl\u0131l\u0131klar\u0131 g\u00f6stermi\u015ftir. Bu durum, hematoloji alan\u0131ndaki yay\u0131n politikalar\u0131n\u0131n ve k\u00fclt\u00fcrel normlar\u0131n ne denli de\u011fi\u015fken oldu\u011funu ortaya koymaktad\u0131r.<\/p>\n<p>T\u0131bbi yaz\u0131m\u0131n finansman\u0131 incelendi\u011finde, %89 gibi b\u00fcy\u00fck \u00e7o\u011funlu\u011funun end\u00fcstri sponsorlar\u0131 taraf\u0131ndan sa\u011fland\u0131\u011f\u0131 belirlenmi\u015ftir. \u0130la\u00e7 firmalar\u0131n\u0131n destekledi\u011fi bu finansman modeli, bilimsel metinlerin tarafs\u0131zl\u0131\u011f\u0131n\u0131 ve g\u00fcvenilirli\u011fini sorgulayan ciddi endi\u015felere yol a\u00e7maktad\u0131r. End\u00fcstri kaynakl\u0131 deste\u011fin fazla olmas\u0131, tedavi ya da ila\u00e7 lehine bilin\u00e7li ya da bilin\u00e7siz y\u00f6nlendirmeleri ve bilimsel anlat\u0131lar \u00fczerinden pazarlama etkilerini beraberinde getirebilmektedir.<\/p>\n<p>Hematolojik maligniteler i\u00e7inde plazma h\u00fccresi hastal\u0131klar\u0131 \u00fczerine yap\u0131lan derlemelerde t\u0131bbi yaz\u0131m\u0131n en fazla kullan\u0131ld\u0131\u011f\u0131 ve oran\u0131n\u0131n %11\u2019e ula\u015ft\u0131\u011f\u0131 g\u00f6r\u00fclm\u00fc\u015ft\u00fcr. Bu alt alandaki y\u00fcksek kullan\u0131m oran\u0131, \u00f6zellikle multipl miyelom gibi dikkat \u00e7eken hastal\u0131klar\u0131n mevcut olmas\u0131 ve bu alanlardaki yo\u011fun ila\u00e7 geli\u015ftirme rekabetiyle ba\u011flant\u0131l\u0131d\u0131r. B\u00f6ylece, ticari \u00f6nceliklerin t\u0131bbi yaz\u0131m hizmetlerine olan talebi art\u0131rd\u0131\u011f\u0131 s\u00f6ylenebilir.<\/p>\n<p>\u00c7al\u0131\u015fma, yazarlar\u0131n finansal \u00e7\u0131kar \u00e7at\u0131\u015fmalar\u0131n\u0131 da de\u011ferlendirmi\u015ftir. \u0130lk yazarlar\u0131n %28\u2019i, son yazarlar\u0131n ise %34\u2019\u00fc do\u011frudan \u00f6demeler ya da di\u011fer ticari ili\u015fkilerle ilgili \u00e7\u0131kar \u00e7at\u0131\u015fmas\u0131 bildirmi\u015ftir. \u00d6zellikle belirli ila\u00e7lara odaklanan derlemelerde bu oran %71\u2019e kadar y\u00fckselmi\u015f, bu da yazarlar\u0131n finansal menfaatlerinin i\u00e7erik \u00fczerindeki etkisine i\u015faret etmi\u015ftir. B\u00f6yle y\u00fcksek bir oran, tarafs\u0131z kan\u0131t sentezlerinin olu\u015fturulmas\u0131nda zorluklar do\u011furmakta ve hematoloji literat\u00fcr\u00fcn\u00fcn g\u00fcvenilirli\u011fine g\u00f6lge d\u00fc\u015f\u00fcrmektedir.<\/p>\n<p>Dergiler aras\u0131nda t\u0131bbi yaz\u0131m hizmetlerine y\u00f6nelik a\u00e7\u0131k politika uygulayanlar\u0131n say\u0131s\u0131 olduk\u00e7a azd\u0131r; yaln\u0131zca bir dergi inceleme kapsam\u0131ndaki makaleler i\u00e7in bu konuda net kurallar koymu\u015ftur. Bu durum, yay\u0131nc\u0131l\u0131kta \u015feffafl\u0131k, hesap verebilirlik ve etik normlar\u0131n uygulanmas\u0131nda \u00f6nemli bir bo\u015flu\u011fa i\u015faret etmektedir. Edit\u00f6ryal denetim eksikli\u011fi, t\u0131bbi yaz\u0131m\u0131n eksik ya da tutars\u0131z \u015fekilde bildirilmesine engel olamamakta ve potansiyel \u00e7\u0131kar \u00e7at\u0131\u015fmalar\u0131n\u0131n \u00f6n\u00fcne ge\u00e7ilememektedir.<\/p>\n<p>T\u0131bbi yaz\u0131m\u0131n etik boyutu yaln\u0131zca yard\u0131m\u0131n tan\u0131nmas\u0131 meselesiyle s\u0131n\u0131rl\u0131 kalmamaktad\u0131r. Yazar listesine dahil edilmeyen t\u0131bbi yazarlar, katk\u0131lar\u0131n\u0131n g\u00f6rmezden gelinmesine yol a\u00e7arken, firma sponsorlu\u011funda y\u00fcr\u00fct\u00fclen yaz\u0131m faaliyetleri bilimsel ileti\u015fim ile ticari \u00e7\u0131karlar aras\u0131nda dikkatli bir denge gerektirmektedir. Bu hassas dengenin korunmamas\u0131, bilim toplulu\u011fundaki g\u00fcveni sarsmakta ve tarafs\u0131zl\u0131\u011f\u0131n zedelenmesine neden olmaktad\u0131r.<\/p>\n<p>Hematoloji alan\u0131ndaki derleme makalelerinde t\u0131bbi yaz\u0131m\u0131n ortaya konmas\u0131, end\u00fcstri etkisinin kan\u0131t sentezi, klinik rehberler ve konsens\u00fcs bildirimleri yoluyla nas\u0131l n\u00fcfuz edebilece\u011fini g\u00f6stermektedir. Bu durum, \u00e7\u00fcnk\u00fc derlemeler klinisyenler, ara\u015ft\u0131rmac\u0131lar, politika yap\u0131c\u0131lar ve hastalar i\u00e7in temel referans materyali olu\u015fturmaktad\u0131r. Dolay\u0131s\u0131yla, bu kritik yay\u0131nlardaki t\u0131bbi yaz\u0131m\u0131n yayg\u0131nl\u0131\u011f\u0131, finansman\u0131 ve yazar ili\u015fkilerinin detayl\u0131 incelenmesi, hematoloji ara\u015ft\u0131rma yay\u0131nlar\u0131n\u0131n \u015feffafl\u0131\u011f\u0131n\u0131 ve objektifli\u011fini art\u0131rmak i\u00e7in elzemdir.<\/p>\n<p>\u00c7al\u0131\u015fma, t\u0131bbi yaz\u0131m ve \u00e7\u0131kar \u00e7at\u0131\u015fmas\u0131 bildirimlerinin etik s\u0131n\u0131rlar\u0131 hakk\u0131ndaki tart\u0131\u015fmalara yeni bir boyut kazand\u0131rmaktad\u0131r. \u00d6zellikle hayalet yazarl\u0131k, \u015feffafl\u0131k ve end\u00fcstri sponsorlu\u011funun rol\u00fcne ili\u015fkin endi\u015feler, biyomedikal yay\u0131nc\u0131l\u0131\u011f\u0131n g\u00fcndeminde uzun s\u00fcredir bulunmaktad\u0131r. Bu ara\u015ft\u0131rma, dar bir alanda g\u00f6zlemlenen belirgin kal\u0131plar\u0131 belgeleyerek mevcut yay\u0131n politikalar\u0131n\u0131n yeniden de\u011ferlendirilmesini ve t\u0131bbi yaz\u0131m katk\u0131lar\u0131n\u0131n a\u00e7\u0131k\u00e7a d\u00fczenlenmesini te\u015fvik etmektedir.<\/p>\n<p>Hematoloji d\u0131\u015f\u0131ndaki t\u0131p dallar\u0131nda da ila\u00e7 end\u00fcstrisi kaynakl\u0131 t\u0131bbi yaz\u0131m\u0131n \u00f6nemli rol oynad\u0131\u011f\u0131 d\u00fc\u015f\u00fcn\u00fcl\u00fcrse, bu bulgular\u0131n evrensel en iyi uygulama k\u0131lavuzlar\u0131n\u0131n geli\u015ftirilmesi i\u00e7in yol g\u00f6sterici oldu\u011fu g\u00f6r\u00fclmektedir. Bilimsel incelemenin korunmas\u0131 ve yay\u0131n eti\u011finin g\u00fc\u00e7lendirilmesi ad\u0131na t\u0131bbi yaz\u0131m\u0131n y\u00f6netilmesi, k\u00fcresel \u00f6l\u00e7ekte t\u00fcm t\u0131p disiplinlerine uygulanabilecek standartlar\u0131n olu\u015fturulmas\u0131na katk\u0131 sa\u011flayabilir.<\/p>\n<p>Sonu\u00e7 olarak, hematolojik maligniteler alan\u0131nda yay\u0131mlanan derleme makalelerinde t\u0131bbi yaz\u0131m\u0131n oran\u0131 nispeten d\u00fc\u015f\u00fck olmakla birlikte, b\u00fcy\u00fck oranda end\u00fcstri sponsorlu olmas\u0131 \u00f6nemli bir dikkat noktas\u0131d\u0131r. Yazarlardaki y\u00fcksek finansal \u00e7\u0131kar \u00e7at\u0131\u015fmas\u0131 oran\u0131 ve ila\u00e7 odakl\u0131 yay\u0131nlarda bu oran\u0131n y\u00fckselmesi, edit\u00f6ryal yakla\u015f\u0131mlar\u0131n s\u0131k\u0131la\u015ft\u0131r\u0131lmas\u0131 ve bildirim kurallar\u0131n\u0131n g\u00fc\u00e7lendirilmesi gereklili\u011fini ortaya koymaktad\u0131r. \u00c7\u00fcnk\u00fc derlemelerin klinik karar verme s\u00fcre\u00e7leri ile sa\u011fl\u0131k politikalar\u0131 \u00fczerinde do\u011frudan etkisi bulunmaktad\u0131r ve g\u00fcvenilirli\u011fin korunmas\u0131 bilimsel yay\u0131nc\u0131l\u0131\u011f\u0131n temel ta\u015f\u0131d\u0131r.<\/p>\n<p>Geli\u015fmi\u015f ve d\u00fczenli edit\u00f6ryal politikalar, t\u0131bbi yaz\u0131m\u0131n bildirilmesi, \u00e7\u0131kar \u00e7at\u0131\u015fmas\u0131 y\u00f6netimi ve yazar haklar\u0131n\u0131n korunmas\u0131 konular\u0131nda standartlar\u0131n belirlenmesini sa\u011flayabilir. Bu t\u00fcr yakla\u015f\u0131mlar, ara\u015ft\u0131rmac\u0131lar\u0131n, klinisyenlerin ve okuyucular\u0131n bilimsel bilginin kayna\u011f\u0131n\u0131 ve b\u00fct\u00fcnl\u00fc\u011f\u00fcn\u00fc do\u011fru de\u011ferlendirmelerine olanak tan\u0131r. Biyomedikal bilimin h\u0131zla ilerledi\u011fi g\u00fcn\u00fcm\u00fczde, etik titizlikle y\u00fcr\u00fct\u00fclen bilimsel anlat\u0131, g\u00fcvenilir ve anlaml\u0131 bilgi aktar\u0131m\u0131 i\u00e7in vazge\u00e7ilmezdir.<\/p>\n<p>&#8212;<\/p>\n<p><strong>Ara\u015ft\u0131rma Konusu<\/strong>: Malign hematoloji derleme makalelerinde t\u0131bbi yaz\u0131m\u0131n yayg\u0131nl\u0131\u011f\u0131 ve yazarlar\u0131n finansal \u00e7\u0131kar \u00e7at\u0131\u015fmalar\u0131 ile ili\u015fkisi.<\/p>\n<p><strong>Makale Ba\u015fl\u0131\u011f\u0131<\/strong>: Prevalence of medical writing in hematological malignancy review articles<\/p>\n<p><strong>Web References<\/strong>: https:\/\/doi.org\/10.1186\/s12885-025-14137-5<\/p>\n<p><strong>Doi Referans<\/strong>: https:\/\/doi.org\/10.1186\/s12885-025-14137-5<\/p>\n<p><strong>Resim Credits<\/strong>: Scienmag.com<\/p>\n<p><strong>Anahtar Kelimeler<\/strong>: klinik rehberler onkolojide, ara\u015ft\u0131rmada \u00e7\u0131kar \u00e7at\u0131\u015fmalar\u0131, t\u0131bbi yaz\u0131mda etik endi\u015feler, t\u0131bbi yazarlar\u0131n finansman kaynaklar\u0131, bilimsel literat\u00fcrde t\u0131bbi yaz\u0131m etkisi, end\u00fcstri etkisi ve ara\u015ft\u0131rma yaz\u0131m\u0131, hematolojide t\u0131bbi yaz\u0131m, anlat\u0131sal derlemeler hematoloji, hematoloji alan\u0131nda bilimsel ileti\u015fim, hematolojik malignite sistematik derlemesi, hematoloji derleme makale trendleri<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Son y\u0131llarda t\u0131bbi yaz\u0131m hizmetleri, \u00f6zellikle hematoloji alan\u0131nda haz\u0131rlanan bilimsel makalelerde hem etkili hem de tart\u0131\u015fmal\u0131 bir rol \u00fcstlenmektedir. Ba\u015flang\u0131\u00e7ta karma\u015f\u0131k ara\u015ft\u0131rma makalelerinin haz\u0131rlanmas\u0131n\u0131 kolayla\u015ft\u0131rmay\u0131 hedefleyen bu hizmetler, zamanla etik kayg\u0131lar\u0131 da beraberinde getirmi\u015ftir. End\u00fcstri etkisinin akademik yay\u0131na s\u0131zma riski, t\u0131bbi yaz\u0131m\u0131n kullan\u0131m\u0131nda \u015feffafl\u0131k ve \u00e7\u0131kar \u00e7at\u0131\u015fmalar\u0131 konusundaki endi\u015feleri art\u0131rmaktad\u0131r. BMC Cancer dergisinde yay\u0131mlanan son&#8230;<\/p>\n","protected":false},"author":1,"featured_media":2960,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_yoast_wpseo_title":"","_yoast_wpseo_metadesc":"","_yoast_wpseo_focuskw":"","rank_math_title":"","rank_math_description":"","rank_math_focus_keyword":"","_wpan_schema_json_ld":"","_wpan_ai_seo_metadata":"","_wpan_ai_seo_status":"","_wpan_ai_seo_policy":"","_wpan_ai_seo_faq_block":"","_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[28],"tags":[973,970,971,974,972],"tmauthors":[],"class_list":{"0":"post-2959","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-kanser","8":"tag-hematoloji-derleme-makalelerinde-endustri-sponsorlugu","9":"tag-hematoloji-tibbi-yazim-trendleri","10":"tag-hematolojik-malignitelerde-tibbi-yazim-kullanimi","11":"tag-plazma-hucresi-hastaliklarinda-tibbi-yazim-etkisi","12":"tag-tibbi-yazimda-etik-ve-cikar-catismalari"},"jetpack_featured_media_url":"https:\/\/haber360.com\/wp-content\/uploads\/2025\/04\/Hematoloji-Incelemelerinde-Tibbi-Yazim-Trendleri-1744894779.jpg","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/posts\/2959","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/comments?post=2959"}],"version-history":[{"count":0,"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/posts\/2959\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/media\/2960"}],"wp:attachment":[{"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/media?parent=2959"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/categories?post=2959"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/tags?post=2959"},{"taxonomy":"tmauthors","embeddable":true,"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/tmauthors?post=2959"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}